Dr. Timothy Roberts Uses Imaging to Measure Autism Treatment Response (VIDEO)

Dr. Timothy Roberts of Childrens Hospital of Philadelphia (CHOP) Center for Autism Research (CAR) is using MEG technology to measure the biological response to new medical treatments in children with autism. Eventually, he says, MEG will be used to determine which children with autism are most likely to respond to a given treatment. CHOP is participating in the ongoing arboclofen trials, sponsored by Seaside Therapeutics, for children with Fragile X and is using MEG technology as a noninvasive way to measure the biological changes in the brain that result from arboclofen intervention. Dr. Roberts also explains the value of imaging for developing new autism treatments and improving existing treatments.